Robert E. Rydell

2.3k total citations · 1 hit paper
27 papers, 1.8k citations indexed

About

Robert E. Rydell is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Robert E. Rydell has authored 27 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 7 papers in Molecular Biology and 6 papers in Genetics. Recurrent topics in Robert E. Rydell's work include Acute Myeloid Leukemia Research (7 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Robert E. Rydell is often cited by papers focused on Acute Myeloid Leukemia Research (7 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Robert E. Rydell collaborates with scholars based in United States and Sweden. Robert E. Rydell's co-authors include Costan W. Berard, Hugh Bonner, Risa B. Mann, John M. Bennett, Maurice Barcos, Richard S. Neiman, Martin M. Oken, F. W. Hoffbauer, Kathy Foucar and Heike Gutmann and has published in prestigious journals such as New England Journal of Medicine, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Robert E. Rydell

27 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Granulocytic sarcoma: A clinicopathologic study of 61 biopsied cases

1981 745 citations Robert E. Rydell et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert E. Rydell United States	16	1.1k	484	380	278	256	27	1.8k
George Omura United States	18	1.0k 0.9×	240 0.5×	532 1.4×	619 2.2×	84 0.3×	52	2.5k
Emmanuel C. Besa United States	23	1.0k 0.9×	693 1.4×	425 1.1×	167 0.6×	70 0.3×	68	1.7k
Mario Masi Italy	17	1.1k 1.0×	429 0.9×	488 1.3×	220 0.8×	58 0.2×	23	1.6k
Parameswaran Venugopal United States	21	1.1k 1.0×	482 1.0×	684 1.8×	412 1.5×	131 0.5×	130	1.9k
Edoardo Ascari Italy	25	623 0.6×	557 1.2×	873 2.3×	566 2.0×	37 0.1×	96	2.2k
Álvaro Aguayo Mexico	19	867 0.8×	501 1.0×	933 2.5×	506 1.8×	60 0.2×	46	1.8k
Canellos Gp United States	20	516 0.5×	412 0.9×	116 0.3×	361 1.3×	31 0.1×	49	1.3k
AnneMarie W. Block United States	20	926 0.8×	408 0.8×	543 1.4×	278 1.0×	36 0.1×	62	1.6k
Arthur Haut United States	24	913 0.8×	549 1.1×	601 1.6×	1.0k 3.7×	30 0.1×	48	2.3k
N Jamal Canada	17	607 0.6×	237 0.5×	218 0.6×	210 0.8×	36 0.1×	35	1.3k

Countries citing papers authored by Robert E. Rydell

Since Specialization

Citations

This map shows the geographic impact of Robert E. Rydell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert E. Rydell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert E. Rydell more than expected).

Fields of papers citing papers by Robert E. Rydell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert E. Rydell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert E. Rydell. The network helps show where Robert E. Rydell may publish in the future.

Co-authorship network of co-authors of Robert E. Rydell

This figure shows the co-authorship network connecting the top 25 collaborators of Robert E. Rydell. A scholar is included among the top collaborators of Robert E. Rydell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert E. Rydell. Robert E. Rydell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rydell, Robert E., et al.. (1992). Increased Response to Cisplatin After Long-Term Serial Passage of a Squamous-Cell Carcinoma Xenograft. PubMed. 5(1). 485–488. 1 indexed citations

Pomeroy, Claire, Martin M. Oken, Robert E. Rydell, & Gregory Filice. (1991). Infection in the myelodysplastic syndromes. The American Journal of Medicine. 90(1). 338–344. 71 indexed citations

Pomeroy, Claire, Martin M. Oken, Robert E. Rydell, & Gregory Filice. (1991). Infection in the myelodysplastic syndromes. The American Journal of Medicine. 90(3). 338–344. 30 indexed citations

Rydell, Robert E. & Johan Wennerberg. (1990). Cisplatin-Fluorouracil Interaction in a Squamous Cell Carcinoma Xenograft. Archives of Otolaryngology - Head and Neck Surgery. 116(10). 1172–1176. 2 indexed citations

Yunis, Jorge J., Michael Lobell, Mark A. Arnesen, et al.. (1988). Refined chromosome study helps define prognostic subgroups in most patients with primary myelodysplastic syndrome and acute myelogenous leukaemia. British Journal of Haematology. 68(2). 189–194. 187 indexed citations

Ascensão, João L., Neil E. Kay, James R. Wright, et al.. (1986). Lymphoblastic transformation of myelodysplastic syndrome. American Journal of Hematology. 22(4). 431–434. 26 indexed citations

Weisdorf, Daniel J., Martin M. Oken, Gerhard J. Johnson, & Robert E. Rydell. (1983). Chronic myelodysplastic syndrome: short survival with or without evolution to acute leukaemia. British Journal of Haematology. 55(4). 691–700. 118 indexed citations

Rosenberg, William, Martin M. Oken, Robert E. Rydell, & Manuel E. Kaplan. (1982). Non-Hodgkin’s Lymphoma after Treatment for Hodgkin’s Disease. Oncology. 39(4). 216–217. 4 indexed citations

Weisdorf, Daniel J., Martin M. Oken, Gerhard J. Johnson, & Robert E. Rydell. (1981). Auer rod positive dysmyelopoietic syndrome. American Journal of Hematology. 11(4). 397–402. 15 indexed citations

10.

Rydell, Robert E., et al.. (1980). Inhibitory Effect of Disulfiram on Rat Mammary Tumor Induction By N-2-Fluorenylacetamide and on its Metabolic Conversion To N-Hydroxy-N-2-fluorenylacetamide2. JNCI Journal of the National Cancer Institute. 64(6). 1471–1477. 17 indexed citations

11.

Gordon, Leo I., William J.M. Hrushesky, Martin M. Oken, Neil E. Kay, & Robert E. Rydell. (1979). Chronic lymphocytic leukemia in association with a second lymphoproliferative disorder: Response to chemotherapy in two cases. Medical and Pediatric Oncology. 7(2). 111–116. 1 indexed citations

12.

Oken, Martin M., P. S. Sarin, Robert C. Gallo, et al.. (1978). Terminal transferase levels in chronic myelogenous leukemia in blast crisis and in remission. Leukemia Research. 2(2). 173–180. 16 indexed citations

13.

Malejka‐Giganti, Danuta, Robert E. Rydell, & Heike Gutmann. (1977). Mammary carcinogenesis in the rat by topical application of fluorenylhydroxamic acids and their acetates.. PubMed. 37(1). 111–7. 17 indexed citations

14.

Gutmann, Heike, et al.. (1975). The carcinogenicity of fluorenylhydroxamic acids and N-acetoxy-N-fluorenylacetamides for the rat as related to the reactivity of the esters toward nucleophiles.. PubMed. 35(2). 447–59. 9 indexed citations

15.

Malejka‐Giganti, Danuta, Heike Gutmann, & Robert E. Rydell. (1973). Mammary carcinogenesis in the rat by topical application of fluorenylhydroxamic acids.. PubMed. 33(10). 2489–97. 15 indexed citations

16.

Malejka‐Giganti, Danuta, et al.. (1973). Malignant Transformation of Rat Embryo Fibroblasts by Carcinogenic Fluorenylhydroxamic Acids In Vitro2. JNCI Journal of the National Cancer Institute. 50(5). 1337–1345. 7 indexed citations

17.

Gutmann, Heike, et al.. (1972). On the correlation between the hepatocarcinogenicity of the carcinogen, N-2-fluorenylacetamide, and its metabolic activation by the rat.. PubMed. 32(7). 1554–61. 49 indexed citations

18.

Rydell, Robert E. & Jack L. Pulec. (1971). Arnold-Chiari Malformation: Neuro-otologic Symptoms. Archives of Otolaryngology - Head and Neck Surgery. 94(1). 8–12. 21 indexed citations

19.

Malejka‐Giganti, Danuta, et al.. (1971). Activation of the carcinogen, N-hydroxy-2-fluorenylbenzene-sulfonamide, by desulfonylation to N-2-fluorenylhydroxylamine in vivo.. PubMed. 31(6). 778–88. 9 indexed citations

20.

Gutmann, Heike, et al.. (1970). Structure-activity relationships of N-acylarylhydroxylamines in the rat.. PubMed. 30(5). 1485–98. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact